INDUSTRY PROFILE
The diagnostics and genomics industry depends on academic medical centers and university genomics labs to validate assays, supply clinical cohorts, and pioneer methods like single-cell and spatial sequencing. Companies recruit bioinformaticians and genomics PhDs and engage academic key opinion leaders to drive clinical adoption of new tests. Biobank access and sponsored biomarker research with university pathology departments are central to bringing diagnostics to market.
MARKET SIZE
$98B
KEY COMPANIES
10
TARGET RESEARCHERS
Genomicists, bioinformaticians, clinical pathologists, and assay-development scientists working on sequencing, liquid biopsy, and single-cell methods
KEY COMPANIES
Illumina
Guardant Health
Grail
Natera
Exact Sciences
Tempus
Foundation Medicine
Oxford Nanopore
Pacific Biosciences
10x Genomics
USE CASES
Assay validation with academic medical centers
Recruiting genomics and bioinformatics PhDs
Clinical-cohort and biobank partnerships
Single-cell and spatial method co-development
KOL engagement for diagnostic adoption
Sponsored research on novel biomarkers
TRY IT
Install the CLI and run your first search in under a minute. No account required to explore.
npx sci-buy@latest COPIED